ArticleCancers2021

The Prognostic Value of Whole-Blood PSMB5, CXCR4, POMP, and RPL5 mRNA Expression in Patients with Multiple Myeloma Treated with Bortezomib.

Pawel Robak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.